REGENEREX PHARMA, INC — Net Income by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/dd0a5db2-d5ca-4119-b35f-24d15fa47965/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-2.5M | 2024-04-01 – 2025-03-31 | evidence 0001472375-25-000070 |
| FY 2023 | $-3.5M | 2023-04-01 – 2024-03-31 | evidence 0001472375-24-000045 |
| FY 2022 | $-137.3k | 2022-04-01 – 2023-03-31 | evidence 0001472375-23-000090 |
| FY 2021 | $-195.6k | 2021-04-01 – 2022-03-31 | evidence 0001472375-22-000055 |
| FY 2020 | $-353.8k | 2020-04-01 – 2021-03-31 | evidence 0001472375-22-000055 |
| FY 2019 | $111.6k | 2019-04-01 – 2020-03-31 | evidence 0001472375-21-000044 |
| FY 2018 | $-93.6k | 2018-04-01 – 2019-03-31 | evidence 0001472375-19-000028 |
| FY 2017 | $-49.7k | 2017-04-01 – 2018-03-31 | evidence 0001472375-18-000067 |
| FY 2016 | $-2.6k | 2016-04-01 – 2017-03-31 | evidence 0001472375-18-000067 |
| FY 2014 | $-1.0M | 2010-06-26 – 2014-11-30 | evidence 0001472375-15-000062 |
| FY 2013 | $-922.0k | 2010-06-26 – 2014-05-31 | evidence 0001072588-14-000066 |
| FY 2012 | $-1.4M | 2010-06-26 – 2013-05-31 | evidence 0001072588-13-000080 |
| FY 2011 | $391.1k | 2010-06-26 – 2012-05-31 | evidence 0001072588-12-000097 |
| FY 2010 | $-27.4k | 2009-12-01 – 2010-11-30 | evidence 0001072588-12-000027 |
| FY 2009 | $-6.4k | 2008-12-01 – 2009-11-30 | evidence 0001072588-12-000027 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
REGENEREX PHARMA, INC — all facts · Revenue · Operating Income